Carestream Molecular Imaging markets PET/CT/SPECT system

Carestream Molecular Imaging, a division of Carestream Health has signed a multi-year agreement with Valencia, Spain-based OncoVision to sell, market and service the Albira PET/SPECT/CT imaging system for pre-clinical small animal imaging.

The Albira system features a modular architecture that introduces a patented single-crystal detector and associated electronics for acquisition and reconstruction of quantitative PET and SPECT images, according to Woodbridge, Conn.- based Carestream Molecular Imaging.

The system will be introduced at the American Association of Cancer Research (AACR) annual meeting in Washington, D.C., April 18-21.

Around the web

The new technology shows early potential to make a significant impact on imaging workflows and patient care. 

Richard Heller III, MD, RSNA board member and senior VP of policy at Radiology Partners, offers an overview of policies in Congress that are directly impacting imaging.
 

The two companies aim to improve patient access to high-quality MRI scans by combining their artificial intelligence capabilities.